Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplement
Compositions and methods for combination therapy are provided. The compositions comprise a multiple unit dosage form having both a therapeutic agent and a nutritional supplement. The combination therapy is useful for restoring a nutrient depletion associated with a particular disease state. Additionally, the combination therapy can prevent or attenuate the depletion of a nutrient caused, in whole or in part, by the co-administrated therapeutic drug. Methods of manufacturing the formulations are likewise described.
1. A dosage form for oral administration comprising:
an inner therapeutic agent;
a middle barrier layer disposed over the therapeutic agent, wherein the therapeutic agent is an anti-oxidant, anti-inflammatory, or combinations thereof; and
an outer nutritional supplement layer disposed over the barrier layer, wherein the nutritional supplement layer consists of a nutritional supplement and one or more additional components selected from the group consisting of a pharmaceutically acceptable carrier, a sweetener, a flavoring agent, a coloring agent, a preservative, and an excipient, and wherein the nutritional supplement comprises one or more of a linoleic acid, an herbal extract, a botanical extract, or a combination thereof;
wherein said inner therapeutic agent and outer nutritional supplement layer are formulated as a single dose.
2. The dosage form of claim 1 , wherein the therapeutic agent is provided in a therapeutically effective amount.
3. The dosage form of claim 1 , wherein the barrier layer is comprised of a controlled-release, delayed-release, or enteric coating.
4. The dosage form of claim 1 , wherein the dosage form is provided as a fast dispersing form.
5. The dosage form of claim 1 , further comprising an outer coating.
6. A dosage form for oral administration comprising:
an inner therapeutic agent layer;
a middle barrier layer disposed over the therapeutic agent layer, wherein the therapeutic agent layer comprises one or more of an anti-oxidant, anti-inflammatory, or combinations thereof; and
an outer nutritional supplement layer disposed over the barrier layer, wherein the nutritional supplement layer consists of a nutritional supplement and one or more additional components selected from the group consisting of a pharmaceutically acceptable carrier, a sweetener, a flavoring agent, a coloring agent, a preservative, and an excipient, and wherein the nutritional supplement comprises one or more of a linoleic acid, an herbal extract, a botanical extract, or a combination thereof;
wherein said inner therapeutic agent layer and outer nutritional supplement layer are formulated as a single dose.
7. The dosage form of claim 6 , wherein the therapeutic agent is provided in a therapeutically effective amount.
8. The dosage form of claim 6 , wherein the barrier layer is comprised of a controlled-release, delayed-release, or enteric coating.
9. The dosage form of claim 6 , wherein the dosage form is provided as a fast dispersing form.
10. The dosage form of claim 6 , further comprising an outer coating.
11. A dosage form for oral administration comprising:
an inner therapeutic agent;
a middle barrier layer disposed over the therapeutic agent; and
an outer nutritional supplement layer disposed over the barrier layer, wherein the nutritional supplement layer consists of a nutritional supplement and one or more additional components selected from the group consisting of a pharmaceutically acceptable carrier, a sweetener, a flavoring agent, a coloring agent, a preservative, and an excipient, and wherein the nutritional supplement comprises one or more of a linoleic acid, an herbal extract, a botanical extract, or a combination thereof;
wherein said inner therapeutic agent and outer nutritional supplement layer are formulated as a single dose.
12. The dosage form of claim 11 , wherein the therapeutic agent is provided in a therapeutically effective amount.
13. The dosage form of claim 11 , wherein the barrier layer is comprised of a controlled-release, delayed-release, or enteric coating.
14. The dosage form of claim 11 , wherein the dosage form is provided as a fast dispersing form.
15. The dosage form of claim 11 , further comprising an outer coating.